Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
8,825 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials.
Ma ML, Ma ZJ, He YL, et al. · Front Public Health · 2022Meta-Analysis, Systematic Review
- A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis.
Singh S, Dutta S, Khasbage S, et al. · Osteoporos Int · 2022Meta-Analysis, Systematic Review
- Quality of life in postmenopausal women with osteoporosis: a systematic review and meta-analysis.
Gao S, Zhao Y · Qual Life Res · 2023Meta-Analysis, Systematic Review
- Cardiovascular Safety of Romosozumab Compared to Commonly Used Anti-osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.
Cheng SH, Chu W, Chou WH, et al. · Drug Saf · 2025Systematic Review, Comparative Study
- Assessing the Efficacy of Romosozumab in Postmenopausal Osteoporosis: An Updated Systematic Review and Meta-analysis.
Ferrer BL, Garcia MSM, Herrera SR, et al. · J Clin Rheumatol · 2025Systematic Review, Meta-Analysis
- Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study.
Jeka S, Dokoupilová E, Kivitz A, et al. · J Bone Miner Res · 2024Clinical Trial, Phase I, Clinical Trial, Phase II
- 3 months vs 12 months of romosozumab for postmenopausal osteoporosis (LIDA): an open-label, non-inferiority, randomised controlled trial.
Leder BZ, Ramchand SK, Jordan M, et al. · Lancet Diabetes Endocrinol · 2026Randomized Controlled Trial, Equivalence Trial
- The effect of vitamin K2 supplementation on bone turnover biochemical markers in postmenopausal osteoporosis patients: a systematic review and meta-analysis.
Zhang Z, Li Y, Li J, et al. · Front Endocrinol (Lausanne) · 2025Systematic Review, Meta-Analysis
- Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
Neer RM, Arnaud CD, Zanchetta JR, et al. · N Engl J Med · 2001Clinical Trial, Multicenter Study
- Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial.
Wong RH, Thaung Zaw JJ, Xian CJ, et al. · J Bone Miner Res · 2020Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis.
Bone HG, Cosman F, Miller PD, et al. · J Clin Endocrinol Metab · 2018Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Effects of Combined Exercise and Calcium/Vitamin D Supplementation on Bone Mineral Density in Postmenopausal Women: A Systematic Review and Meta-Analysis.
Bai J, Huang W, Yan R, et al. · Nutrients · 2025Systematic Review, Meta-Analysis
- Prevalence of postmenopausal osteoporosis in Morocco: a systematic review and meta-analysis.
Kherrab A, Toufik H, Ghazi M, et al. · Arch Osteoporos · 2024Systematic Review, Meta-Analysis
- Combination therapy for postmenopausal osteoporosis.
Compston JE, Watts NB · Clin Endocrinol (Oxf) · 2002Meta-Analysis
- Monitoring alendronate therapy for osteoporosis.
Braga de Castro Machado A, Hannon R, Eastell R · J Bone Miner Res · 1999Clinical Trial, Randomized Controlled Trial
- Calcitonin, estrogens and the bone.
Gennari C, Agnusdei D · J Steroid Biochem Mol Biol · 1990Clinical Trial, Randomized Controlled Trial
- Efficacy of traditional Chinese exercise on postmenopausal osteoporosis: a systematic review and meta-analysis.
Li L, Wang Y, Fan T, et al. · J Orthop Surg Res · 2024Systematic Review, Meta-Analysis
- The Safety and Efficacy of Abaloparatide on Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis.
Xu F, Wang Y, Zhu X · Clin Ther · 2024Meta-Analysis, Systematic Review
- Association between Postmenopausal Osteoporosis and IL-6ஹTNF-α: A Systematic Review and A Meta-analysis.
Huang X, Ni B, Li Q, et al. · Comb Chem High Throughput Screen · 2024Systematic Review, Meta-Analysis
- Puerarin for OVX-Induced Postmenopausal Osteoporosis in Murine Model: Systematic Review and Meta-Analysis.
Yang X, Zheng H, Liu Y, et al. · Curr Stem Cell Res Ther · 2020Meta-Analysis, Systematic Review
- Performance of clinical prediction models for identifying postmenopausal osteoporosis: a systematic review and meta-analysis.
Huang X, Gan Y, Guo X, et al. · BMC Musculoskelet Disord · 2026Systematic Review, Meta-Analysis
- Mood effect of raloxifene in postmenopausal women.
Jarkova NB, Martenyi F, Masanauskaite D, et al. · Maturitas · 2002Clinical Trial, Randomized Controlled Trial
- MiR-503 regulates osteoclastogenesis via targeting RANK.
Chen C, Cheng P, Xie H, et al. · J Bone Miner Res · 2014Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Pulse Electromagnetic Field for Treating Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Lang S, Ma J, Gong S, et al. · Bioelectromagnetics · 2022Meta-Analysis, Systematic Review
- Effectiveness of anabolic and anti-resorptive agents for preventing postmenopausal osteoporosis fractures: a systematic review and network meta-analysis.
Su P, Li M, Xiao J, et al. · J Orthop Surg Res · 2025Network Meta-Analysis, Systematic Review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.